CN201522494U - 双联法便潜血快速诊断层析试纸 - Google Patents
双联法便潜血快速诊断层析试纸 Download PDFInfo
- Publication number
- CN201522494U CN201522494U CN2009200961696U CN200920096169U CN201522494U CN 201522494 U CN201522494 U CN 201522494U CN 2009200961696 U CN2009200961696 U CN 2009200961696U CN 200920096169 U CN200920096169 U CN 200920096169U CN 201522494 U CN201522494 U CN 201522494U
- Authority
- CN
- China
- Prior art keywords
- test paper
- occult blood
- cushion
- sample pad
- pasted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000012360 testing method Methods 0.000 title claims abstract description 55
- 210000004369 blood Anatomy 0.000 title claims abstract description 40
- 239000008280 blood Substances 0.000 title claims abstract description 40
- 238000000034 method Methods 0.000 claims abstract description 68
- 239000000126 substance Substances 0.000 claims abstract description 28
- 239000004033 plastic Substances 0.000 claims abstract description 12
- 229920003023 plastic Polymers 0.000 claims abstract description 12
- 238000002955 isolation Methods 0.000 claims abstract description 10
- 239000000020 Nitrocellulose Substances 0.000 claims abstract description 9
- 229920001220 nitrocellulos Polymers 0.000 claims abstract description 9
- 238000003908 quality control method Methods 0.000 claims abstract description 6
- 102000001554 Hemoglobins Human genes 0.000 claims description 34
- 108010054147 Hemoglobins Proteins 0.000 claims description 34
- 230000002550 fecal effect Effects 0.000 claims description 30
- 238000001514 detection method Methods 0.000 claims description 16
- 238000003745 diagnosis Methods 0.000 claims description 15
- 239000000428 dust Substances 0.000 claims description 4
- 239000004745 nonwoven fabric Substances 0.000 claims description 4
- 241001494479 Pecora Species 0.000 claims description 3
- 239000004743 Polypropylene Substances 0.000 claims description 2
- 239000002250 absorbent Substances 0.000 claims description 2
- 230000002745 absorbent Effects 0.000 claims description 2
- HGAZMNJKRQFZKS-UHFFFAOYSA-N chloroethene;ethenyl acetate Chemical group ClC=C.CC(=O)OC=C HGAZMNJKRQFZKS-UHFFFAOYSA-N 0.000 claims description 2
- -1 polypropylene Polymers 0.000 claims description 2
- 229920001155 polypropylene Polymers 0.000 claims description 2
- 229920000915 polyvinyl chloride Polymers 0.000 claims description 2
- 239000004800 polyvinyl chloride Substances 0.000 claims description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 abstract description 27
- 239000010931 gold Substances 0.000 abstract description 12
- 229910052737 gold Inorganic materials 0.000 abstract description 12
- 238000002360 preparation method Methods 0.000 abstract description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 7
- 230000035945 sensitivity Effects 0.000 abstract description 7
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 abstract description 6
- 201000010099 disease Diseases 0.000 abstract description 6
- 238000009534 blood test Methods 0.000 abstract description 5
- 238000003317 immunochromatography Methods 0.000 abstract description 5
- 239000007788 liquid Substances 0.000 abstract description 4
- 239000012528 membrane Substances 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 3
- 238000003759 clinical diagnosis Methods 0.000 abstract description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 3
- 230000008569 process Effects 0.000 abstract description 2
- 238000012216 screening Methods 0.000 abstract description 2
- 238000003556 assay Methods 0.000 abstract 1
- 230000003993 interaction Effects 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 239000000084 colloidal system Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- 208000032843 Hemorrhage Diseases 0.000 description 5
- 239000000427 antigen Substances 0.000 description 5
- 102000036639 antigens Human genes 0.000 description 5
- 108091007433 antigens Proteins 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 238000013016 damping Methods 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 description 4
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 4
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 238000006555 catalytic reaction Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 150000002978 peroxides Chemical class 0.000 description 4
- 239000002689 soil Substances 0.000 description 4
- 108010017480 Hemosiderin Proteins 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- YQHLDYVWEZKEOX-UHFFFAOYSA-N cumene hydroperoxide Chemical compound OOC(C)(C)C1=CC=CC=C1 YQHLDYVWEZKEOX-UHFFFAOYSA-N 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 229920002538 Polyethylene Glycol 20000 Polymers 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- NMWONDKHBZEDMY-UHFFFAOYSA-H [Au](Cl)(Cl)Cl.C(CC(O)(C(=O)[O-])CC(=O)[O-])(=O)[O-].[Na+].[Na+].[Na+] Chemical compound [Au](Cl)(Cl)Cl.C(CC(O)(C(=O)[O-])CC(=O)[O-])(=O)[O-].[Na+].[Na+].[Na+] NMWONDKHBZEDMY-UHFFFAOYSA-H 0.000 description 2
- 238000004159 blood analysis Methods 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229920000151 polyglycol Polymers 0.000 description 2
- 239000010695 polyglycol Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- RMMXTBMQSGEXHJ-UHFFFAOYSA-N Aminophenazone Chemical compound O=C1C(N(C)C)=C(C)N(C)N1C1=CC=CC=C1 RMMXTBMQSGEXHJ-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000147041 Guaiacum officinale Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229960000212 aminophenazone Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- HFACYLZERDEVSX-UHFFFAOYSA-N benzidine Chemical compound C1=CC(N)=CC=C1C1=CC=C(N)C=C1 HFACYLZERDEVSX-UHFFFAOYSA-N 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000005354 coacervation Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000001839 endoscopy Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- FDWREHZXQUYJFJ-UHFFFAOYSA-M gold monochloride Chemical compound [Cl-].[Au+] FDWREHZXQUYJFJ-UHFFFAOYSA-M 0.000 description 1
- 229940091561 guaiac Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000003024 molecular redistribution determination method Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 102000013415 peroxidase activity proteins Human genes 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000013316 zoning Methods 0.000 description 1
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009200961696U CN201522494U (zh) | 2009-04-03 | 2009-04-03 | 双联法便潜血快速诊断层析试纸 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009200961696U CN201522494U (zh) | 2009-04-03 | 2009-04-03 | 双联法便潜血快速诊断层析试纸 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN201522494U true CN201522494U (zh) | 2010-07-07 |
Family
ID=42508672
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009200961696U Expired - Lifetime CN201522494U (zh) | 2009-04-03 | 2009-04-03 | 双联法便潜血快速诊断层析试纸 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN201522494U (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103487578A (zh) * | 2013-10-16 | 2014-01-01 | 深圳市大爱医疗科技有限公司 | 一种crp/pct联合诊断试纸及其制备方法 |
CN104515859A (zh) * | 2014-12-17 | 2015-04-15 | 杭州慧缘泰医疗器械有限公司 | 血红蛋白、血红蛋白-结合珠蛋白复合物、转铁蛋白联检试剂盒及其制备方法、检测方法 |
CN104950107A (zh) * | 2014-03-25 | 2015-09-30 | 兰州红虫生物工程有限责任公司 | 一种可同时检测尿素和三聚氰胺的试纸条 |
CN105467124A (zh) * | 2015-12-18 | 2016-04-06 | 厦门稀土材料研究所 | 一种检测便隐血的胶体金双联试纸条及其制备方法 |
CN106199017A (zh) * | 2016-09-27 | 2016-12-07 | 重庆大学 | 一种隐血检测层析试纸 |
CN107727850A (zh) * | 2017-10-10 | 2018-02-23 | 北京康华源科技发展有限公司 | 一种侧向流层析检测反应启动控制方法 |
CN111044470A (zh) * | 2019-12-31 | 2020-04-21 | 大连德泰克森生物医药有限公司 | 一种血红蛋白半定量检测试剂及便潜血标本采集和检测的方法 |
-
2009
- 2009-04-03 CN CN2009200961696U patent/CN201522494U/zh not_active Expired - Lifetime
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103487578A (zh) * | 2013-10-16 | 2014-01-01 | 深圳市大爱医疗科技有限公司 | 一种crp/pct联合诊断试纸及其制备方法 |
CN104950107A (zh) * | 2014-03-25 | 2015-09-30 | 兰州红虫生物工程有限责任公司 | 一种可同时检测尿素和三聚氰胺的试纸条 |
CN104515859A (zh) * | 2014-12-17 | 2015-04-15 | 杭州慧缘泰医疗器械有限公司 | 血红蛋白、血红蛋白-结合珠蛋白复合物、转铁蛋白联检试剂盒及其制备方法、检测方法 |
CN105467124A (zh) * | 2015-12-18 | 2016-04-06 | 厦门稀土材料研究所 | 一种检测便隐血的胶体金双联试纸条及其制备方法 |
CN106199017A (zh) * | 2016-09-27 | 2016-12-07 | 重庆大学 | 一种隐血检测层析试纸 |
CN107727850A (zh) * | 2017-10-10 | 2018-02-23 | 北京康华源科技发展有限公司 | 一种侧向流层析检测反应启动控制方法 |
CN111044470A (zh) * | 2019-12-31 | 2020-04-21 | 大连德泰克森生物医药有限公司 | 一种血红蛋白半定量检测试剂及便潜血标本采集和检测的方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN201522494U (zh) | 双联法便潜血快速诊断层析试纸 | |
CN104502586B (zh) | 一种免疫层析检测方法及试纸 | |
EP2376906B1 (en) | Method for amplification of signal in immunochromatographic assay and immunochromatographic kit using the method | |
US8927262B2 (en) | Ovulation predictor test | |
CN202794178U (zh) | 降钙素原快速定量免疫层析检测试剂盒 | |
DK165932B (da) | Anordning og fremgangsmaade til hurtig kvalitativ og kvantitativ bestemmelse af tilstedevaerelsen af en reaktiv ligand i et fluidum | |
CN101893627A (zh) | 金磁微粒标记免疫层析快速检测方法 | |
CN101965515A (zh) | 用于检测潜血的方法和装置 | |
CN103926400A (zh) | 特异性测定IgM和IgG和IgA血型抗体的试纸条 | |
CN102650642A (zh) | 一种用于检测人视黄醇结合蛋白4的抗体复合物及免疫层析检测卡和试剂盒 | |
CN104777298B (zh) | 一种检测装置 | |
CN201607444U (zh) | 便潜血快速诊断的层析试纸 | |
CN102830234A (zh) | 一种检测人心力衰竭新型标志物st2的快速诊断试剂盒 | |
CN115097129B (zh) | 一种用于胎盘生长因子和可溶性fms样酪氨酸激酶-1的检测试剂组合 | |
JPWO2015080286A1 (ja) | イムノクロマトグラフィーを利用した検出方法 | |
JP3609240B2 (ja) | 免疫学的検査法および免疫学的検査用キット | |
CN201087838Y (zh) | 心肌钙蛋白i颜色颗粒诊断试纸 | |
CN201413329Y (zh) | 爱泼斯坦-巴尔病毒衣壳抗原和胸苷激酶蛋白免疫球蛋白a抗体联合检测试纸 | |
EP2049903B1 (en) | An immunochromatography device for the diagnosis of diseases in a sample | |
EP2110668A1 (en) | Detection test assembly for detecting the presence of a substance in a sample | |
CN101655496A (zh) | 解脲支原体抗体唾液快速检测试纸条 | |
CN202583214U (zh) | 一种新型人c-反应蛋白胶体金检测试纸条 | |
CN201096787Y (zh) | C-反应蛋白颜色颗粒诊断试纸 | |
US20230026892A1 (en) | Lateral flow assay for detecting multiple proteins of a pathogen | |
CN1740794B (zh) | 横向流动检测生物标本中特异性抗体的方法及其检测装置 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of utility model: Duplex occult blood fast diagnositic and chromatographic test paper Effective date of registration: 20121210 Granted publication date: 20100707 Pledgee: Tianjin TEDA Small Enterprise Credit Guarantee Center Pledgor: Newscen Coast Bio-Pharmaceutical Co., Ltd. Registration number: 2012990000773 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of utility model: Duplex occult blood fast diagnositic and chromatographic test paper Effective date of registration: 20140212 Granted publication date: 20100707 Pledgee: Tianjin TEDA Small Enterprise Credit Guarantee Center Pledgor: Newscen Coast Bio-Pharmaceutical Co., Ltd. Registration number: 2014120000005 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20131224 Granted publication date: 20100707 Pledgee: Tianjin TEDA Small Enterprise Credit Guarantee Center Pledgor: Newscen Coast Bio-Pharmaceutical Co., Ltd. Registration number: 2012990000773 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20141231 Granted publication date: 20100707 Pledgee: Tianjin TEDA Small Enterprise Credit Guarantee Center Pledgor: Newscen Coast Bio-Pharmaceutical Co., Ltd. Registration number: 2014120000005 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of utility model: Duplex occult blood fast diagnositic and chromatographic test paper Effective date of registration: 20150204 Granted publication date: 20100707 Pledgee: Tianjin TEDA Small Enterprise Credit Guarantee Center Pledgor: Newscen Coast Bio-Pharmaceutical Co., Ltd. Registration number: 2015120000009 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20160307 Granted publication date: 20100707 Pledgee: Tianjin TEDA Small Enterprise Credit Guarantee Center Pledgor: Newscen Coast Bio-Pharmaceutical Co., Ltd. Registration number: 2015120000009 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 300457 Binhai New Area, Tianjin economic and Technological Development Zone, No. sixth main street, No. 65 Patentee after: Tianjin new torch bio pharmaceutical Limited by Share Ltd Address before: 300150 Tianjin Development Zone, Sixth Street, No. 65 Patentee before: Newscen Coast Bio-Pharmaceutical Co., Ltd. |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20100707 |